Tag: genomic selection platform market size

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Genomic Selection Platform Market Value Expansion And Long-Term Growth Outlook

Within the realm of genomic selection platforms, a significant expansion has been observed recently. Projections indicate a robust increase from $2.27 billion in 2025 to an estimated $2.66 billion by 2026, reflecting a compound annual growth rate of 17.1%. This upward trajectory during the preceding period was fueled by several key factors, including the widespread implementation of molecular breeding initiatives, the advancing accessibility of genotyping techniques, the integration of statistical genomics models, a growing need for accelerated breeding processes, and escalating financial commitments to genetic research.

The market for genomic selection platforms is poised for substantial expansion over the coming years, projected to reach $4.96 billion by 2030 with a compound annual growth rate of 16.8%. This projected growth is fueled by several key factors, including the increasing integration of genomic selection within agricultural practices, a heightened reliance on predictive analytics for breeding initiatives, the burgeoning field of sustainable agriculture and livestock development, the growing synergy between genomics and precision agriculture, and the ongoing evolution of cloud-native genomic solutions. During this forecast period, prominent trends will involve a greater embrace of AI-powered genomic prediction models, expanded utilization of high-throughput genotyping technologies, deeper integration of cloud-based breeding analytics, the proliferation of predictive breeding decision support systems, and a more concentrated emphasis on achieving superior accuracy in trait-based selection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Genomic Selection Platform Market Expansion Drivers: What Is Shaping Future Growth?

A significant catalyst for the expansion of the genomic selection platform market is the increasing emphasis on personalized medicine. This approach customizes healthcare strategies based on an individual’s distinct genetic profile, habits, and surroundings. The growing prevalence of personalized medicine stems largely from innovations in genomics, which allow for the accurate identification of genetic variations and the development of individualized therapies. Genomic selection platforms play a crucial role in facilitating personalized medicine by offering detailed genetic insights, thereby enabling the precise tailoring of treatments to each patient. By predicting responses to various interventions, these platforms minimize the hit-or-miss nature of treatment selection, leading to more effective therapies and better patient results. For example, the Personalized Medicine Coalition (PMC) noted that in 2023, the U.S. Food and Drug Administration (FDA) authorized 26 new personalized medicines, a notable increase from the 12 approved in 2022, highlighting the growing momentum of this field and, consequently, the demand for genomic selection platforms.

Genomic Selection Platform Market Driver: Increasing Crop Yields Fueling The Growth Of The Market Due To Enhancing Agricultural Productivity And Efficient Breeding

The anticipated rise in crop yields is poised to stimulate the expansion of the genomic selection platform market. Crop yield, representing the agricultural output per unit of land, is experiencing an upswing thanks to progress in agricultural biotechnology that strengthens plant genetics and their capacity to withstand environmental challenges. Genomic selection platforms contribute to augmenting crop yields by facilitating the accurate identification and selection of superior plant varieties, making them invaluable tools for contemporary agriculture and breeding initiatives. These platforms streamline the breeding process, reducing both the time and expenses associated with traditional methods through precise genetic forecasting, ultimately boosting agricultural productivity and bolstering global food security. Illustrating this trend, the Central Statistics Office of Ireland reported in May 2025 that potato production saw a substantial annual increase of 46,100 tonnes, reaching 368,300 tonnes in 2024. Furthermore, potato yield per hectare grew by 1.0% to 39.6 tonnes, with the cultivation area expanding by 1,100 hectares (13.2%) compared to the previous year, covering 9,300 hectares in 2024. This demonstrable growth in crop yields underscores the market-driving influence of increased agricultural output on the genomic selection platform sector.

Genomic Selection Platform Market Segmentation And Category Breakdown

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

Genomic Selection Platform Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Companies prominent within the genomic selection platform sector are dedicating their efforts toward creating novel solutions, including sophisticated targeted sequencing platforms, with the aim of enhancing trait prediction accuracy and expediting the progression of breeding initiatives. These targeted sequencing platforms represent advanced genomic technologies and systems engineered for the precise sequencing of predetermined genomic areas, rather than encompassing the entirety of the genome. Illustrating this trend, in October 2024, Element Biosciences Inc., a biotechnology firm headquartered in the United States, introduced Trinity, a revolutionary targeted sequencing platform. This innovative system simplifies the process of exome capture by incorporating steps that were previously intricate directly into their AVITI System. The Trinity platform eradicates the requirement for specialized instrumentation, curtails manual labor by as much as five hours, and provides a hybridization option that can yield results within a single hour, thus proving exceptionally beneficial for time-critical research. Furthermore, Trinity accommodates custom panels catering to a broad spectrum of applications, including oncology, respiratory ailments, and the detection of minimal residual disease (MRD), thereby facilitating quicker, more economical, and readily accessible sequencing, signifying a significant leap forward in exome capture technology.

Genomic Selection Platform Market Competitive Analysis Of Major Industry Participants

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Access The Complete Genomic Selection Platform Market Report:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Genomic Selection Platform Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Genomic Selection Platform Market Value Expansion And Long-Term Growth Outlook

Within the realm of genomic selection platforms, a significant expansion has been observed recently. Projections indicate a robust increase from $2.27 billion in 2025 to an estimated $2.66 billion by 2026, reflecting a compound annual growth rate of 17.1%. This upward trajectory during the preceding period was fueled by several key factors, including the widespread implementation of molecular breeding initiatives, the advancing accessibility of genotyping techniques, the integration of statistical genomics models, a growing need for accelerated breeding processes, and escalating financial commitments to genetic research.

The market for genomic selection platforms is poised for substantial expansion over the coming years, projected to reach $4.96 billion by 2030 with a compound annual growth rate of 16.8%. This projected growth is fueled by several key factors, including the increasing integration of genomic selection within agricultural practices, a heightened reliance on predictive analytics for breeding initiatives, the burgeoning field of sustainable agriculture and livestock development, the growing synergy between genomics and precision agriculture, and the ongoing evolution of cloud-native genomic solutions. During this forecast period, prominent trends will involve a greater embrace of AI-powered genomic prediction models, expanded utilization of high-throughput genotyping technologies, deeper integration of cloud-based breeding analytics, the proliferation of predictive breeding decision support systems, and a more concentrated emphasis on achieving superior accuracy in trait-based selection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Genomic Selection Platform Market Expansion Drivers: What Is Shaping Future Growth?

A significant catalyst for the expansion of the genomic selection platform market is the increasing emphasis on personalized medicine. This approach customizes healthcare strategies based on an individual’s distinct genetic profile, habits, and surroundings. The growing prevalence of personalized medicine stems largely from innovations in genomics, which allow for the accurate identification of genetic variations and the development of individualized therapies. Genomic selection platforms play a crucial role in facilitating personalized medicine by offering detailed genetic insights, thereby enabling the precise tailoring of treatments to each patient. By predicting responses to various interventions, these platforms minimize the hit-or-miss nature of treatment selection, leading to more effective therapies and better patient results. For example, the Personalized Medicine Coalition (PMC) noted that in 2023, the U.S. Food and Drug Administration (FDA) authorized 26 new personalized medicines, a notable increase from the 12 approved in 2022, highlighting the growing momentum of this field and, consequently, the demand for genomic selection platforms.

Genomic Selection Platform Market Driver: Increasing Crop Yields Fueling The Growth Of The Market Due To Enhancing Agricultural Productivity And Efficient Breeding

The anticipated rise in crop yields is poised to stimulate the expansion of the genomic selection platform market. Crop yield, representing the agricultural output per unit of land, is experiencing an upswing thanks to progress in agricultural biotechnology that strengthens plant genetics and their capacity to withstand environmental challenges. Genomic selection platforms contribute to augmenting crop yields by facilitating the accurate identification and selection of superior plant varieties, making them invaluable tools for contemporary agriculture and breeding initiatives. These platforms streamline the breeding process, reducing both the time and expenses associated with traditional methods through precise genetic forecasting, ultimately boosting agricultural productivity and bolstering global food security. Illustrating this trend, the Central Statistics Office of Ireland reported in May 2025 that potato production saw a substantial annual increase of 46,100 tonnes, reaching 368,300 tonnes in 2024. Furthermore, potato yield per hectare grew by 1.0% to 39.6 tonnes, with the cultivation area expanding by 1,100 hectares (13.2%) compared to the previous year, covering 9,300 hectares in 2024. This demonstrable growth in crop yields underscores the market-driving influence of increased agricultural output on the genomic selection platform sector.

Genomic Selection Platform Market Segmentation And Category Breakdown

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

Genomic Selection Platform Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Companies prominent within the genomic selection platform sector are dedicating their efforts toward creating novel solutions, including sophisticated targeted sequencing platforms, with the aim of enhancing trait prediction accuracy and expediting the progression of breeding initiatives. These targeted sequencing platforms represent advanced genomic technologies and systems engineered for the precise sequencing of predetermined genomic areas, rather than encompassing the entirety of the genome. Illustrating this trend, in October 2024, Element Biosciences Inc., a biotechnology firm headquartered in the United States, introduced Trinity, a revolutionary targeted sequencing platform. This innovative system simplifies the process of exome capture by incorporating steps that were previously intricate directly into their AVITI System. The Trinity platform eradicates the requirement for specialized instrumentation, curtails manual labor by as much as five hours, and provides a hybridization option that can yield results within a single hour, thus proving exceptionally beneficial for time-critical research. Furthermore, Trinity accommodates custom panels catering to a broad spectrum of applications, including oncology, respiratory ailments, and the detection of minimal residual disease (MRD), thereby facilitating quicker, more economical, and readily accessible sequencing, signifying a significant leap forward in exome capture technology.

Genomic Selection Platform Market Competitive Analysis Of Major Industry Participants

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Access The Complete Genomic Selection Platform Market Report:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Genomic Selection Platform Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Genomic Selection Platform Market Value Expansion And Long-Term Growth Outlook

Within the realm of genomic selection platforms, a significant expansion has been observed recently. Projections indicate a robust increase from $2.27 billion in 2025 to an estimated $2.66 billion by 2026, reflecting a compound annual growth rate of 17.1%. This upward trajectory during the preceding period was fueled by several key factors, including the widespread implementation of molecular breeding initiatives, the advancing accessibility of genotyping techniques, the integration of statistical genomics models, a growing need for accelerated breeding processes, and escalating financial commitments to genetic research.

The market for genomic selection platforms is poised for substantial expansion over the coming years, projected to reach $4.96 billion by 2030 with a compound annual growth rate of 16.8%. This projected growth is fueled by several key factors, including the increasing integration of genomic selection within agricultural practices, a heightened reliance on predictive analytics for breeding initiatives, the burgeoning field of sustainable agriculture and livestock development, the growing synergy between genomics and precision agriculture, and the ongoing evolution of cloud-native genomic solutions. During this forecast period, prominent trends will involve a greater embrace of AI-powered genomic prediction models, expanded utilization of high-throughput genotyping technologies, deeper integration of cloud-based breeding analytics, the proliferation of predictive breeding decision support systems, and a more concentrated emphasis on achieving superior accuracy in trait-based selection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Genomic Selection Platform Market Expansion Drivers: What Is Shaping Future Growth?

A significant catalyst for the expansion of the genomic selection platform market is the increasing emphasis on personalized medicine. This approach customizes healthcare strategies based on an individual’s distinct genetic profile, habits, and surroundings. The growing prevalence of personalized medicine stems largely from innovations in genomics, which allow for the accurate identification of genetic variations and the development of individualized therapies. Genomic selection platforms play a crucial role in facilitating personalized medicine by offering detailed genetic insights, thereby enabling the precise tailoring of treatments to each patient. By predicting responses to various interventions, these platforms minimize the hit-or-miss nature of treatment selection, leading to more effective therapies and better patient results. For example, the Personalized Medicine Coalition (PMC) noted that in 2023, the U.S. Food and Drug Administration (FDA) authorized 26 new personalized medicines, a notable increase from the 12 approved in 2022, highlighting the growing momentum of this field and, consequently, the demand for genomic selection platforms.

Genomic Selection Platform Market Driver: Increasing Crop Yields Fueling The Growth Of The Market Due To Enhancing Agricultural Productivity And Efficient Breeding

The anticipated rise in crop yields is poised to stimulate the expansion of the genomic selection platform market. Crop yield, representing the agricultural output per unit of land, is experiencing an upswing thanks to progress in agricultural biotechnology that strengthens plant genetics and their capacity to withstand environmental challenges. Genomic selection platforms contribute to augmenting crop yields by facilitating the accurate identification and selection of superior plant varieties, making them invaluable tools for contemporary agriculture and breeding initiatives. These platforms streamline the breeding process, reducing both the time and expenses associated with traditional methods through precise genetic forecasting, ultimately boosting agricultural productivity and bolstering global food security. Illustrating this trend, the Central Statistics Office of Ireland reported in May 2025 that potato production saw a substantial annual increase of 46,100 tonnes, reaching 368,300 tonnes in 2024. Furthermore, potato yield per hectare grew by 1.0% to 39.6 tonnes, with the cultivation area expanding by 1,100 hectares (13.2%) compared to the previous year, covering 9,300 hectares in 2024. This demonstrable growth in crop yields underscores the market-driving influence of increased agricultural output on the genomic selection platform sector.

Genomic Selection Platform Market Segmentation And Category Breakdown

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

Genomic Selection Platform Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Companies prominent within the genomic selection platform sector are dedicating their efforts toward creating novel solutions, including sophisticated targeted sequencing platforms, with the aim of enhancing trait prediction accuracy and expediting the progression of breeding initiatives. These targeted sequencing platforms represent advanced genomic technologies and systems engineered for the precise sequencing of predetermined genomic areas, rather than encompassing the entirety of the genome. Illustrating this trend, in October 2024, Element Biosciences Inc., a biotechnology firm headquartered in the United States, introduced Trinity, a revolutionary targeted sequencing platform. This innovative system simplifies the process of exome capture by incorporating steps that were previously intricate directly into their AVITI System. The Trinity platform eradicates the requirement for specialized instrumentation, curtails manual labor by as much as five hours, and provides a hybridization option that can yield results within a single hour, thus proving exceptionally beneficial for time-critical research. Furthermore, Trinity accommodates custom panels catering to a broad spectrum of applications, including oncology, respiratory ailments, and the detection of minimal residual disease (MRD), thereby facilitating quicker, more economical, and readily accessible sequencing, signifying a significant leap forward in exome capture technology.

Genomic Selection Platform Market Competitive Analysis Of Major Industry Participants

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Access The Complete Genomic Selection Platform Market Report:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Genomic Selection Platform Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Genomic Selection Platform Market During The Forecast Period?

The genomic selection platform market has experienced significant expansion in recent years. It is anticipated to grow from $2.27 billion in 2025 to $2.66 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.1%. This historical growth can be linked to the proliferation of molecular breeding programs, enhanced availability of genotyping technologies, the adoption of statistical genomics models, an increasing need for more rapid breeding cycles, and rising research investments in genetics.

The genomic selection platform market size is anticipated to experience substantial growth in the coming years. It is projected to achieve a value of $4.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.8%. This expansion during the forecast period can be primarily attributed to the increasing adoption of genomic selection in agricultural practices, the rising application of predictive analytics in breeding programs, the wider development of sustainable crops and livestock, the growing integration of genomics with precision agriculture, and the advancement of cloud-native genomic platforms. Significant trends foreseen for the same period include the increasing incorporation of AI-driven genomic prediction models, the rising utilization of high-throughput genotyping platforms, the expanding integration of cloud-based breeding analytics, the enhancement of predictive breeding decision support systems, and a more pronounced focus on trait-based selection accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Genomic Selection Platform Market?

The expanding integration of personalized medicine is anticipated to fuel the expansion of the genomic selection platform market in the coming years. Personalized medicine represents a healthcare strategy focused on customizing treatment and prevention approaches to align with an individual’s distinct genetic composition, way of life, and surroundings. This rising embrace of personalized medicine is largely attributable to progress in genomics, which facilitates precise identification of genetic variations and the development of customized treatments for individuals. Genomic selection platforms play a crucial role in personalized medicine by delivering accurate genomic insights, making them perfectly suited for customizing patient treatments. These platforms minimize experimental approaches in therapy selection by forecasting responses to various interventions, thereby enhancing treatment efficacy and improving patient health outcomes. For example, in February 2024, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, a notable rise from the 12 approved in 2022, as reported by the US-based nonprofit organization, the Personalized Medicine Coalition (PMC). Consequently, the growing acceptance of personalized medicine is a key driver for the genomic selection platform market.

How Is Segmentation Applied In The Genomic Selection Platform Market Segment Analysis?

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

Which Trends Are Shaping The Genomic Selection Platform Market?

Entities within the genomic selection platform market are prioritizing the development of innovative offerings, such as targeted sequencing platforms, to enhance trait prediction and accelerate breeding programs. Targeted sequencing platforms refer to genomic technologies designed to sequence specific regions of the genome rather than the entire genome. For example, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, an advanced targeted sequencing platform that simplifies exome capture by integrating traditionally complex steps into its AVITI System. This platform removes the need for specialized equipment, reduces manual processing time by up to five hours, and offers a one-hour hybridization option for same-day results, making it well-suited for time-sensitive research. Trinity also supports custom panels for applications such as oncology, respiratory diseases, and minimal residual disease (MRD), delivering faster, more cost-efficient, and accessible sequencing while marking a significant advancement in exome capture technology.

Who Are The Companies Participating In The Genomic Selection Platform Market Environment?

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Get The Full Genomic Selection Platform Market Report:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Which Region Has The Greatest Market Share In The Genomic Selection Platform Market?

North America was the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Genomic Selection Platform Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

Browse Through More Reports Similar to the Global Genomic Selection Platform Market 2026, By The Business Research Company

Bioinformatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Genomic Selection Platform Market By The End Of 2030?

The genomic selection platform market has seen substantial growth in recent years. It is expected to expand from $2.27 billion in 2025 to $2.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. This historical growth can be attributed to the expansion of molecular breeding programs, increasing availability of genotyping technologies, the adoption of statistical genomics models, a rising demand for faster breeding cycles, and growing research investments in genetics.

The genomic selection platform market is set to experience substantial expansion over the next few years, with its valuation expected to reach $4.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.8%. This projected increase during the forecast period is driven by factors such as the growing adoption of genomic selection within agriculture, the rising application of predictive analytics in breeding programs, the broadening development of sustainable crop and livestock, the increasing integration of genomics with precision agriculture, and advancements in cloud-native genomic platforms. Significant trends for the forecast period include the increasing uptake of AI-driven genomic prediction models, the expanding use of high-throughput genotyping platforms, the growing integration of cloud-based breeding analytics, the wider implementation of predictive breeding decision support systems, and a heightened focus on the accuracy of trait-based selection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp

Which Market Drivers Are Supporting The Expansion Of The Genomic Selection Platform Market?

The expanding acceptance of personalized medicine is anticipated to drive the progress of the genomic selection platform market moving forward. Personalized medicine is a medical approach that customizes treatment and prevention strategies based on an individual’s distinct genetic makeup, lifestyle, and environment. The growing adoption of personalized medicine is mainly due to advances in genomics, which allow for the precise identification of genetic variations and customized treatments for individuals. Genomic selection platforms bolster personalized medicine by offering precise genomic insights, making them well-suited for tailoring treatments to individual patients. They minimize trial-and-error in therapy selection through predicting responses to interventions, thereby enhancing treatment effectiveness and improving patient outcomes. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant rise from the 12 approved in 2022. Consequently, the increasing adoption of personalized medicine is propelling the growth of the genomic selection platform market.

Genomic Selection Platform Market Driver: Increasing Crop Yields Fueling The Growth Of The Market Due To Enhancing Agricultural Productivity And Efficient Breeding

Which Segment Classifications Shape The Genomic Selection Platform Market?

The genomic selection platform market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications

4) By End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Subsegments:

1) By Software: Genomic Data Management Software, Bioinformatics And Statistical Analysis Tools, DNA Or RNA Sequencing Data Processing Software, Genomic Prediction And Modeling Software, Cloud-Based Genomic Platforms, Workflow Automation And Integration Tools

2) By Hardware: Next-Generation Sequencing (NGS) Systems, Polymerase Chain Reaction (PCR) Instruments, Microarray Analyzers, High-Performance Computing (HPC) Systems, Data Storage Servers, Laboratory Automation And Robotics

3) By Services: Sequencing And Genotyping Services, Data Analysis And Interpretation Services, Cloud Hosting And Data Storage Services, Custom Bioinformatics Solutions, Training And Technical Support Services, Consulting And Implementation Services

How Are Trends Shaping The Direction Of The Genomic Selection Platform Market?

Leading companies in the genomic selection platform market are concentrating on developing innovative solutions, such as targeted sequencing platforms, to enhance trait prediction and accelerate breeding programs. Targeted sequencing platforms are genomic technologies and systems designed to sequence specific regions of the genome instead of the entire genome. For instance, in October 2024, Element Biosciences Inc., a US-based life sciences technology company, launched Trinity, a breakthrough targeted sequencing platform that streamlines exome capture by directly integrating traditionally complex steps into its AVITI System. The platform removes the necessity for specialized equipment, decreases manual work by up to five hours, and provides a one-hour hybridization option for same-day results, rendering it ideal for time-sensitive studies. Trinity extends its support to custom panels across diverse applications like oncology, respiratory diseases, and minimal residual disease (MRD). It delivers quicker, more cost-effective, and more accessible sequencing, signifying the first major advancement in exome capture.

Which Companies Are Expanding Their Footprint In The Genomic Selection Platform Market?

Major companies operating in the genomic selection platform market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., Enigma Genomics Inc.

Read the full genomic selection platform market report here:

https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report

How Is The Genomic Selection Platform Market Distributed Across Key Geographic Regions?

North America was the largest region in the genomic selection platform market in 2025. The regions covered in the genomic selection platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Genomic Selection Platform Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28237&type=smp

Browse Through More Reports Similar to the Global Genomic Selection Platform Market 2026, By The Business Research Company

Genomics Global Market Report

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Data Cleaning Tools Global Market Report

https://www.thebusinessresearchcompany.com/report/data-cleaning-tools-global-market-report

Next Generation Sequencing Market

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model